Clinical Trial

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Unblinded, randomized study of 5-fraction LATTICE radiotherapy (20 Gy with an SIB to 66.7 Gy in 5 fractions) versus moderately dose-escalated palliative radiation (25 Gy in 5 fractions)
Trial Details
NCT Number NCT07594431
Lead Sponsor Stanford University
Conditions Metastases, Metastatic Cancer
Enrollment 80 participants
Start Date 2026-08
Primary Completion 2028-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-18